S&P 500 7,718.60 −0.38%
Nasdaq 26,506.99 −0.29%
S&P/TSX 36,513.80 −0.33%
Apple 319.97 −2.51%
Nvidia 230.36 +0.84%
Microsoft 499.70 −2.04%
Shopify 200.76 −0.10%
Royal Bank 291.48 −0.30%
CAD/USD 0.7231 −0.29%
CLOSED · 17:45 ET
Market ClerkRecap
Sun Sep 6 · markets closed2 signals today321 insider buys this week · $404MCIRO short report next: Sep 15The week ahead
CJ
INSIDER · MAZE · Maze Therapeutics, Inc. · CHIEF EXECUTIVE OFFICER

Coloma Jason V

Every open-market transaction filed under this name, Sep 1 to Sep 3.

Filings
6
0 buys · 6 sells
Bought
open market, at cost
Sold
$1.5M
includes scheduled sales
Buys since
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Sep 3MAZEMaze Therapeutics, Inc.Chief Executive OfficerSell129$25.77$3K+1.7%
Sep 3MAZEMaze Therapeutics, Inc.Chief Executive OfficerSell11,282$26.01$293K+0.8%
Sep 2MAZEMaze Therapeutics, Inc.Chief Executive OfficerSell1,375$27.12$37K−3.4%
Sep 2MAZEMaze Therapeutics, Inc.Chief Executive OfficerSell9,852$26.38$260K−0.6%
Sep 1MAZEMaze Therapeutics, Inc.Chief Executive OfficerSell31,908$26.29$839K−0.3%
Sep 1MAZEMaze Therapeutics, Inc.Chief Executive OfficerSell2,593$26.31$68K−0.4%

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.